Factors associated with false-negative sentinel lymph node biopsy in melanoma patients

Annals of Surgical Oncology

Volumn 17, Issue 3, 2010, Pages 709-717

  Scoggins, Charles R ^a   Martin, Robert C G ^a   Ross, Merrick I ^b   Edwards, Michael J ^c   Reintgen, Douglas S ^d   Urist, Marshall M ^e   Gershenwald, Jeffrey E ^b   Sussman, Jeffrey J ^c   Dirk Noyes, R ^f   Goydos, James S ^g   Beitsch, Peter D ^h   Ariyan, Stephan ⁱ   Stromberg, Arnold J ^j   Hagendoorn, Lee J ^k   McMasters, Kelly M ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d Lakeland Regional Cancer Center   (United States)

^e Kentucky   (United States)

^f LDS HOSPITAL   (United States)

^g RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^h Dallas Surgical Group   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF KENTUCKY   (United States)

^k Advertek Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY;

ADOLESCENT; ADULT; AGED; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 77149161727     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0858-x     Document Type: Article

References (34)

1. American Cancer Society. Cancer Facts and Figures, 2007. 2007.
2. C Chao SL Wong MJ Edwards, et al. 2003 Sentinel lymph node biopsy for head and neck melanomas Ann Surg Oncol. 10 21 26 10.1245/ASO.2003.06.007 12513955
3. C Chao RC Martin MI Ross, et al. 2004 Correlation between prognostic factors and increasing age in melanoma Ann Surg Oncol. 11 259 264 10.1245/ASO.2004.04.015 14993020 (Pubitemid 40486765)
4. KM McMasters 2000 Multiple nodal basin drainage in truncal melanomas Ann Surg Oncol. 7 249 250 10.1007/s10434-000-0249-9 1:STN:280:DC%2BD3c3nslGisA%3D%3D 10819361
5. KM McMasters RD Noyes DS Reintgen, et al. 2004 Lessons learned from the Sunbelt Melanoma Trial J Surg Oncol. 86 212 223 10.1002/jso.20084 15221928 (Pubitemid 38880288)
6. CR Scoggins MI Ross DS Reintgen, et al. 2006 Gender-related differences in outcome for melanoma patients Ann Surg. 243 693 698 10.1097/01.sla. 0000216771.81362.6b 16633005
7. CM Balch SJ Soong JE Gershenwald, et al. 2001 Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol. 19 3622 3634 1:STN:280: DC%2BD3MvlvV2ktA%3D%3D 11504744
8. CM Balch 1992 Cutaneous melanoma: prognosis and treatment results worldwide Semin Surg Oncol. 8 400 414 10.1002/ssu.2980080611 1:STN:280:DyaK3s%2Fmslymtg%3D%3D 1439450
9. JE Gershenwald W Thompson PF Mansfield, et al. 1999 Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol. 17 976 983 1:STN:280:DyaK1M7mvVymsg%3D%3D 10071292
10. JM Thomas EJ Patocskai 2000 The argument against sentinel node biopsy for malignant melanoma BMJ. 321 3 4 10.1136/bmj.321.7252.3 1:STN:280: DC%2BD3czosVaksg%3D%3D 10875809
11. JM Thomas 2008 Prognostic false-positivity of the sentinel node in melanoma Nat Clin Pract Oncol. 5 18 23 10.1038/ncponc1014 18097453
12. DL Morton AJ Cochran JF Thompson, et al. 2005 Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial Ann Surg. 242 302 311 16135917
13. JE Gershenwald MI Colome JE Lee, et al. 1998 Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma J Clin Oncol. 16 2253 2260 1:STN:280:DyaK1c3ovFClug%3D%3D 9626228
14. SP Leong M Kashani-Sabet RA Desmond, et al. 2005 Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up World J Surg. 29 683 691 10.1007/s00268-005-7736-x 15895193 (Pubitemid 41187526)
15. AJ Cochran DL Morton 2006 Detection of clinically relevant melanoma metastases requires focused, not exhaustive, evaluation of sentinel lymph nodes Am J Surg Pathol. 30 419 420 16538068
16. KM McMasters DS Reintgen MI Ross, et al. 2001 Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol. 8 192 197 10.1007/s10434-001-0192-4 1:STN:280:DC%2BD3M3itVGquw%3D%3D 11314933
17. KM McMasters AE Giuliano MI Ross, et al. 1998 Sentinel-lymph-node biopsy for breast cancer-not yet the standard of care N Engl J Med. 339 990 995 10.1056/NEJM199810013391410 1:STN:280:DyaK1cvhvVKmsQ%3D%3D 9753717 (Pubitemid 28455104)
18. L Jansen OE Nieweg JL Peterse, et al. 2000 Reliability of sentinel lymph node biopsy for staging melanoma Br J Surg. 87 484 489 10.1046/j.1365-2168.2000. 01362.x 1:STN:280:DC%2BD3c3itlWjtw%3D%3D 10759748 (Pubitemid 30192962)
19. N Cascinelli E Bombardieri R Bufalino, et al. 2006 Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival J Clin Oncol. 24 4464 4471 10.1200/JCO.2006.06.3198 16983115 (Pubitemid 46630985)
20. GW Carlson AJ Page C Cohen, et al. 2008 Regional recurrence after negative sentinel lymph node biopsy for melanoma Ann Surg. 248 378 386 18791358
21. DL Morton JF Thompson AJ Cochran, et al. 2006 Sentinel-node biopsy or nodal observation in melanoma N Engl J Med. 355 1307 1317 10.1056/NEJMoa060992 1:CAS:528:DC%2BD2sXisVaqtr4%3D 17005948 (Pubitemid 44465459)
22. BM Clary MS Brady JJ Lewis, et al. 2001 Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence Ann Surg. 233 250 258 10.1097/00000658-200102000-00015 1:STN:280:DC%2BD3M7ls1SmtA%3D%3D 11176132 (Pubitemid 32106080)
23. VS Yee JF Thompson JG McKinnon, et al. 2005 Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy Ann Surg Oncol. 12 429 439 10.1245/ASO.2005.03.074 15886905 (Pubitemid 40884257)
24. MG Statius Muller PA van Leeuwen ES de Lange-De Klerk, et al. 2001 The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma Cancer. 91 2401 2408 10.1002/1097-0142(20010615)91:12<2401::AID-CNCR1274>3.0.CO;2-I 1:STN:280:DC%2BD3MzkvFGqsg%3D%3D 11413531 (Pubitemid 32552828)
25. WC Conway MB Faries MB Nicholl, et al. 2009 Age-related lymphatic dysfunction in melanoma patients Ann Surg Oncol. 16 1548 1552 10.1245/s10434-009-0420-x 19277787
26. RZ Karim RA Scolyer W Li, et al. 2008 False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology Ann Surg. 247 1003 1010 10.1097/SLA.0b013e3181724f5e 18520228 (Pubitemid 351770421)
27. DL Morton DR Wen JH Wong, et al. 1992 Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg. 127 392 399 1:STN:280:DyaK383hsFWjsw%3D%3D 1558490
28. R Riber-Hansen P Sjoegren SJ Hamilton-Dutoit, et al. 2008 Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workload Ann Surg Oncol. 15 1492 1501 10.1245/s10434-008-9847-8 18340492
29. C Chao SL Wong MI Ross, et al. 2002 Patterns of early recurrence after sentinel lymph node biopsy for melanoma Am J Surg. 184 520 524 10.1016/S0002-9610(02)01102-9 12488154 (Pubitemid 35477707)
30. L Kretschmer I Beckmann KM Thoms, et al. 2006 Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma Ann Surg Oncol. 13 1105 1112 10.1245/ASO.2006.07. 020 16865591 (Pubitemid 44337970)
31. JC Kang LA Wanek R Essner, et al. 2005 Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma J Clin Oncol. 23 4764 4770 10.1200/JCO.2005.20.537 16034052 (Pubitemid 46224080)
32. L Kretschmer I Beckmann KM Thoms, et al. 2005 Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas Eur J Cancer. 41 531 538 10.1016/j.ejca.2004.11.019 1:STN:280:DC%2BD2M7gslCnuw%3D%3D 15737557 (Pubitemid 40297895)
33. ZI Nowecki P Rutkowski A Nasierowska-Guttmejer, et al. 2006 Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma Ann Surg Oncol. 13 1655 1663 10.1245/s10434-006-9066-0 17016755 (Pubitemid 44951474)
34. C Caraco U Marone E Celentano, et al. 2007 Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma Ann Surg Oncol. 14 2662 2667 10.1245/s10434-007-9433-5 1:STN:280: DC%2BD2srjtVCjsw%3D%3D 17597345 (Pubitemid 47389571)